Matt Kaplan

Matt Kaplan

Director/Board Member at NUVECTIS PHARMA, INC.

Net worth: 3 M $ as of 31/07/2026

58 year
Finance
Consumer Services
Health Technology

Profile

Matthew L.
Kaplan
is an Independent Director at Nuvectis Pharma, Inc. since 2021.
Formerly, Mr. Kaplan was Managing Director & Head of Equity Research at Ladenburg Thalmann & Co., Inc. (Broker) from 2020 to 2025.
Other former roles include Director-Life Sciences Group at Carson Group, Inc. (New York), Research Analyst at Punk Ziegel & Co., and Research Associate at Albert Einstein College of Medicine, Inc. Education includes undergraduate studies at the University of Michigan.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
11/06/2026 159,760 ( 0.51% ) 3 M $ 31/07/2026

Matt Kaplan active positions

CompaniesPositionStart
NUVECTIS PHARMA, INC. Director/Board Member 01/09/2021

Former positions of Matt Kaplan

CompaniesPositionEnd
Director of Research - Equity 01/02/2025
Analyst-Equity 01/05/2008
Corporate Officer/Principal 01/11/2003
Corporate Officer/Principal -
See the detail of Matt Kaplan's experience

Training of Matt Kaplan

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

69

1st degree connections

6

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies6

Finance

Finance

Finance

Consumer Services

Consumer Services

Health Technology